Inogen (INGN) Other Accumulated Expenses (2014 - 2026)
Inogen's (INGN) quarterly Other Accumulated Expenses came in at $1.3 million in Q1 2026, down 49.33% year-on-year from $2.5 million in Q1 2025, and down 65.11% on a QoQ basis from $3.7 million in Q4 2025.
Inogen (INGN) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
Inogen (INGN) has 13 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q1 2026.
- On a quarterly basis, Other Accumulated Expenses fell 49.33% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 49.33% decrease from a year earlier, with the FY2025 full-year figure at $3.7 million, up 25.51% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $1.3 million, down from $3.7 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for INGN reached as high as $4.6 million in Q4 2023 and fell as low as $926000.0 in Q1 2022.
- Historically, Other Accumulated Expenses has averaged $2.1 million across 5 years, with a median of $2.1 million in 2024.
- Across the five-year window, Other Accumulated Expenses surged 154.0% in 2023 and sank 49.33% in 2026, its largest moves.
- Year by year, Other Accumulated Expenses stood at $1.8 million in 2022, then jumped by 154.0% to $4.6 million in 2023, then plunged by 35.59% to $2.9 million in 2024, then climbed by 25.51% to $3.7 million in 2025, then tumbled by 65.11% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.3 million in Q1 2026, $3.7 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Inogen | 175.14 Mn | 64.97 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 3.70 Mn |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 2.48 Mn |
| Mar 31, 2025 | 2.55 Mn |
| Dec 31, 2024 | 2.95 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 4.58 Mn |
| Sep 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 1.76 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 926,000.00 |
| Dec 31, 2021 | 969,000.00 |
| Sep 30, 2021 | 689,000.00 |
| Jun 30, 2021 | 732,000.00 |